isoflavone

Botanicalexperimental

Isoflavones are a type of naturally occurring isoflavonoids, many of which act as phytoestrogens in mammals. Isoflavones occur in many plant species, but are especially high in soybeans. — Wikipedia

Clinical trial activity

26 trials · 32 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
14
Phase 3
5
Phase 4
3

Earliest trial started Feb 1, 2002 (NCT00030147)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2007

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

O=c1c(-c2ccccc2)coc2ccccc12
Mol. weight
222.24 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • isoflavona
  • isoflavone
  • isoflavone
  • isoflavone
  • isoflavones
  • isoflavones
  • novasoy
  • rimostil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03167827Phase 4Sep 30, 2016Federal University of Uberlandia
NCT02373111N/AMar 1, 2015Seoul National University
NCT03008785N/AFeb 28, 2015Federal University of Uberlandia
NCT01695616Phase 3Aug 1, 2013Ache Laboratorios Farmaceuticos S.A.
NCT02806739Early Phase 1 (Phase 1)Jan 1, 2013Hallmark Health System, Tufts University, University of Massachusetts
NCT03844685Phase 2Jul 5, 2012University of Milan
NCT01530893N/AFeb 1, 2012University of East Anglia
NCT01754662N/AOct 1, 2011University of Hull
NCT01377961N/ASep 1, 2010University of Texas, Galveston
NCT01036321Phase 2Dec 1, 2009National Institutes of Health (NIH), University of South Florida
NCT00925639Phase 3Aug 1, 2009University of Sao Paulo
NCT00905723Phase 3May 1, 2009University of Sao Paulo
NCT00354432Phase 3Feb 1, 2007National Cancer Institute (NCI), Wake Forest University
NCT00861588N/AFeb 1, 2006Chinese University of Hong Kong
NCT00245518Phase 4Jun 30, 2005Johns Hopkins University, National Cancer Institute (NCI)
NCT00205179Phase 2Jan 1, 2005National Institutes of Health (NIH), University of Wisconsin
NCT00594620Phase 2Aug 1, 2004Amgen, University of Kansas
NCT01553773Phase 2Jul 1, 2004University of Sao Paulo
NCT00204490Phase 2Apr 1, 2004National Cancer Institute (NCI), National Center for Research Resources (NCRR), University of Texas, Galveston
NCT00596895Phase 2Nov 1, 2003University of Florida
Showing 20 of 26 trials
Page 1 / 2

Organizations

Research & Development (32)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government4132002
University of Sao PauloAcademic/Hospital3322004
Federal University of UberlandiaAcademic/Hospital2222015
National Institute of Mental Health (NIMH)Government2222002
National Institutes of Health (NIH)Government2012005
University of Texas, GalvestonAcademic/Hospital2222004
Ache Laboratorios Farmaceuticos S.A.For profit1112013
AmgenFor profit1012004
Chinese University of Hong KongAcademic/Hospital1112006
European CommissionGovernment1012002
Government of FranceGovernment1012002
Hallmark Health SystemAcademic/Hospital1012013
Harvard UniversityAcademic/Hospital1112003
Johns Hopkins UniversityAcademic/Hospital1112005
National Center for Complementary and Integrative Health (NCCIH)Government1112002
National Center for Research Resources (NCRR)Government1012004
Nichimo Co., LtdFor profit1012003
Seoul National UniversityAcademic/Hospital1112015
Solae, LLCFor profit1012002
TNOFor profit1112002
32 organizations
Page 1 / 2